Curated News
By: NewsRamp Editorial Staff
May 28, 2024

Voyageur Pharmaceuticals Secures $1.9 Million Sales Contract for Latin America

TLDR

  • Voyageur Pharmaceuticals secures a significant sales contract worth USD $1.9 million, positioning the company for market expansion in Latin America.
  • The contract spans three years and involves a distribution partner specializing in radiology drugs in Latin America, with an exclusivity agreement in two countries.
  • This major sales distribution agreement allows Voyageur Pharmaceuticals to expand its market presence across Latin America, offering high-quality imaging products for accurate diagnosis and patient preference.
  • Voyageur Pharmaceuticals CEO Brent Willis announces a significant milestone with the signing of a USD $1.9 million sales contract for Latin America, positioning the company for growth and expansion.

Impact - Why it Matters

The signing of the sales contract by Voyageur Pharmaceuticals marks a significant step forward for the company, positioning it for growth and expansion in the Latin American market. This news signifies potential market success for the company's flagship product, SmoothX®2% w/v, and reflects its commitment to driving sales growth through strategic distribution partnerships.

Summary

Voyageur Pharmaceuticals CEO Brent Willis signed a USD $1.9 million sales contract with a distribution partner in Latin America, marking a significant milestone for the company. The contract includes exclusivity in two Latin American countries and a three-year term, with the partner covering regulatory and licensing costs. The agreement also outlines a pricing structure based on volume milestones to drive sales growth.

The company's flagship product, SmoothX®2% w/v, designed for use in Computed Tomography (CT) of the gastrointestinal tract, will be the lead entry product in this agreement. Voyageur Pharmaceuticals plans to introduce additional products in the future, aiming to expand its market presence across Latin America.

Source Statement

This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Voyageur Pharmaceuticals Secures $1.9 Million Sales Contract for Latin America

blockchain registration record for the source press release.